Anemia / 2023 / Article / Tab 2 / Research Article
Burden of Anemia among Human Immunodeficiency Virus-Positive Adults on Highly Active Antiretroviral Therapy at Hawassa University Compressive Specialized Hospital, Hawassa, Ethiopia Table 2 Baseline clinical characteristics of adult HIV patients on HAART at Hawassa university specialized hospital, 2021 (n = 244).
Background characteristics Not anemic N (%) Anemic N (%) COR (95% CI) TB No 165 (67.6%) 57 (23.3%) Ref Yes 6 (2.5%) 16 (6.6%) 7.719 (2.882–20.679) BMI >18.5 144 (59%) 39 (16%) Ref ≤18.5 27 (11.1%) 34 (13.9%) 4.650 (2.509–8.616) ART regimen Non-AZT-containing 168 (68.9%) 62 (25.4%) 9.935 (2.682–36.801) AZT-containing 3 (1.2%) 11 (4.5%) Ref Duration of ART 6 months–1 year 31 (12.7%) 17 (7%) Ref 1–5 years 74 (30.3%) 26 (10.7%) 0.641 (0.305–1.345) 6–10 years 37 (15.2%) 18 (7.4%) 0.887 (0.392–2.008) >10 years 29 (11.9%) 12 (4.9%) 0.755 (0.308–1.848) Duration of HIV 6 months–1 year 29 (11.9%) 17 (7%) Ref 1–5 years 75 (30.7%) 25 (10.2%) 0.569 (0.268–1.204) 6–10 years 38 (15.6%) 19 (7.8%) 0.853 (0.378–1.924) >10 years 29 (11.9%) 12 (4.9%) 0.706 (0.287–1.737) WHO stage Stage I &II 154 (63.1%) 56 (23%) Ref Stage III & IV 17 (7%) 17 (7%) 2.750 (1.314–5.756) Cotrimoxazole No 147 (60.2%) 43 (17.6%) Ref Yes 24 (9.8%) 30 (12.3%) 4.273 (2.264–8.066) CD4 counts ≥500 97 (39.8%) 23 (9.4%) Ref 200–500 55 (22.5%) 27 (11.1%) 2.070 (1.084–3.954) <200 19 (7.8%) 23 (9.4%) 5.105 (2.390–10.904) Mean cell volume <70 10 (4.1%) 6 (2.5%) Ref 70–100 84 (34.4%) 34 (13.9%) 0.675 (0.227–2.002) >100 77 (31.6%) 33 (13.5%) 0.714 (0.240–2.127)